Jurnal Farmasi Indonesia
Vol. 12 No. 1 (2020): Jurnal Farmasi Indonesia

Monitoring efek samping obat antituberkulosis fase intensif dan lanjutan pasien dewasa tuberkulosis di RSUD Kota Bandung

Siti Thannisa Aisiyah Gumanti (UPN Veteran Jakarta)
Dhigna L. C. P. (UPN Veteran Jakarta)
Via Rifkia (UPN Veteran Jakarta)



Article Info

Publish Date
31 Jan 2022

Abstract

Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis which can be transmitted through sputum splashes. The use of antituberculosis drugs can cause a variety of side effects depending on the duration of TB treatment. Based on TB treatment conditions that have a long duration of drug administration and many types of drugs, there will be a high risk of side effects or toxicity. The purpose of this study was to determine the description of side effects arising from TB drugs at the Bandung City Hospital and the factors causing the incidence of side effects during TB treatment. This research method the author uses a descriptive observational method with a cross sectional approach. The sampling technique uses purposive sampling based on inclusion criteria with a minimum sample of 34 and excursion criteria for TB patients with sepsis complications. The results of the comparative test obtained a p-value of 0.549 > 0.05 which showed that there was no significant difference between the side effects of the drug that arose in new patients and relapse patients.

Copyrights © 2020






Journal Info

Abbrev

jfi

Publisher

Subject

Medicine & Pharmacology

Description

Jurnal Farmasi Indonesia adalah jurnal nasional (peer-reviewed) yang diterbitkan oleh Ikatan Apoteker Indonesia dua kali dalam setahun sebagai sarana diseminasi ilmu pengetahuan di bidang farmasi, yaitu: farmasi klinis, farmasi masyarakat/komunitas, kimia farmasi, biologi farmasi/famakognosi, ...